Intervention for Comorbid Substance Use and Bipolar Disorders
NCT ID: NCT04202393
Last Updated: 2025-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
178 participants
INTERVENTIONAL
2020-10-21
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post-Hospital Intervention for Veterans With Comorbid Bipolar and Substance Use Disorders
NCT04127604
Quetiapine in Patients With Bipolar and Alcohol Abuse/Dependence
NCT00223249
Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Disorder and Substance Abuse Disorder
NCT00194129
Understanding Treatment Adherence Among Individuals With Bipolar Disorder
NCT00183495
Treatment With Quetiapine for Youth With Substance Use Disorders and Severe Mood Dysregulation
NCT02845453
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Integrated Treatment Adherence Program (ITAP)
A combination of in-person and phone sessions along with significant other involvement over 6 months post-hospitalization.
Integrated Treatment Adherence Program (ITAP)
Psychosocial support and treatment to improve treatment adherence, symptoms, and functioning.
Safety Assessment and Follow-up Evaluation (SAFE)
Enhanced symptom monitoring and safety evaluation over 6 months post-hospitalization.
Safety Assessment and Follow-up Evaluation (SAFE)
Enhanced assessment and evaluation with clinician feedback.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Integrated Treatment Adherence Program (ITAP)
Psychosocial support and treatment to improve treatment adherence, symptoms, and functioning.
Safety Assessment and Follow-up Evaluation (SAFE)
Enhanced assessment and evaluation with clinician feedback.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of a substance use disorder
* Taking at least one mood-stabilizing medication
Exclusion:
* Unable to speak and read English
* Younger than age 18
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
Butler Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brandon Gaudiano, PhD
Role: PRINCIPAL_INVESTIGATOR
Butler Hospital
Ivan Miller, PhD
Role: PRINCIPAL_INVESTIGATOR
Butler Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Butler Hospital
Providence, Rhode Island, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1370188-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.